(1S,4R,5R)-2-tert-butoxycarbonyl-2-azabicyclo[2.2.1]heptane-5-carboxylic acid
|
T631815-500mg
|
≥97% |
2165408-95-5 |
500mg
|
¥ 5542.9
|
期货,请咨询 |
阿拉丁 |
(1S,4R,5R)-2-tert-butoxycarbonyl-2-azabicyclo[2.2.1]heptane-5-carboxylic acid
|
T631815-250mg
|
≥97% |
2165408-95-5 |
250mg
|
¥ 3958.9
|
期货,请咨询 |
阿拉丁 |
(1S,4R,5R)-2-tert-butoxycarbonyl-2-azabicyclo[2.2.1]heptane-5-carboxylic acid
|
T631815-1g
|
≥97% |
2165408-95-5 |
1g
|
¥ 9504.9
|
期货,请咨询 |
阿拉丁 |
(1S,4R,5R)-2-tert-butoxycarbonyl-2-azabicyclo[2.2.1]heptane-5-carboxylic acid
|
T631815-100mg
|
≥97% |
2165408-95-5 |
100mg
|
¥ 2374.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R,5S)-2-ethyl-5-methyl-piperazine-1-carboxylate
|
T631814-5g
|
≥97% |
2165403-17-6 |
5g
|
¥ 22471.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R,5S)-2-ethyl-5-methyl-piperazine-1-carboxylate
|
T631814-500mg
|
≥97% |
2165403-17-6 |
500mg
|
¥ 2961.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R,5S)-2-ethyl-5-methyl-piperazine-1-carboxylate
|
T631814-250mg
|
≥97% |
2165403-17-6 |
250mg
|
¥ 1793.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R,5S)-2-ethyl-5-methyl-piperazine-1-carboxylate
|
T631814-1g
|
≥97% |
2165403-17-6 |
1g
|
¥ 4730.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl (2R,5S)-2-ethyl-5-methyl-piperazine-1-carboxylate
|
T631814-100mg
|
≥97% |
2165403-17-6 |
100mg
|
¥ 1120.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl rel-(1R,5S,6s)-6-hydroxy-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
T631813-500mg
|
≥97% |
2165391-70-6 |
500mg
|
¥ 4393.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl rel-(1R,5S,6s)-6-hydroxy-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
T631813-250mg
|
≥97% |
2165391-70-6 |
250mg
|
¥ 2638.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl rel-(1R,5S,6s)-6-hydroxy-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
T631813-1g
|
≥97% |
2165391-70-6 |
1g
|
¥ 7912.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl rel-(1R,5S,6s)-6-hydroxy-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
T631813-100mg
|
≥97% |
2165391-70-6 |
100mg
|
¥ 1648.9
|
期货,请咨询 |
阿拉丁 |
(5R)-4-tert-butoxycarbonyl-1,4-oxazepane-5-carboxylic acid
|
T631812-500mg
|
≥97% |
2165380-89-0 |
500mg
|
¥ 6829.9
|
期货,请咨询 |
阿拉丁 |
(5R)-4-tert-butoxycarbonyl-1,4-oxazepane-5-carboxylic acid
|
T631812-250mg
|
≥97% |
2165380-89-0 |
250mg
|
¥ 4096.9
|
期货,请咨询 |
阿拉丁 |
(5R)-4-tert-butoxycarbonyl-1,4-oxazepane-5-carboxylic acid
|
T631812-1g
|
≥97% |
2165380-89-0 |
1g
|
¥ 12291.9
|
期货,请咨询 |
阿拉丁 |
(5R)-4-tert-butoxycarbonyl-1,4-oxazepane-5-carboxylic acid
|
T631812-100mg
|
≥97% |
2165380-89-0 |
100mg
|
¥ 2558.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 1-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
T631809-5g
|
≥97% |
2164962-36-9 |
5g
|
¥ 8616.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 1-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
T631809-1g
|
≥97% |
2164962-36-9 |
1g
|
¥ 2638.9
|
期货,请咨询 |
阿拉丁 |
tert-butyl 1-acetyl-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
T631809-10g
|
≥97% |
2164962-36-9 |
10g
|
¥ 16371.9
|
期货,请咨询 |
阿拉丁 |
trans-4-aminooxolan-3-ol hydrochloride
|
T631807-5g
|
≥97% |
215940-96-8 |
5g
|
¥ 4703.9
|
期货,请咨询 |
阿拉丁 |
trans-4-aminooxolan-3-ol hydrochloride
|
T631807-1g
|
≥97% |
215940-96-8 |
1g
|
¥ 1176.9
|
期货,请咨询 |
阿拉丁 |
4-tert-butyl 3-methyl (3S)-morpholine-3,4-dicarboxylate
|
T631806-5g
|
≥97% |
215917-98-9 |
5g
|
¥ 1489.9
|
期货,请咨询 |
阿拉丁 |
4-tert-butyl 3-methyl (3S)-morpholine-3,4-dicarboxylate
|
T631806-500mg
|
≥97% |
215917-98-9 |
500mg
|
¥ 160.9
|
期货,请咨询 |
阿拉丁 |